Glenmark introduces the Sacu VTM to treat chronic heart failure

Glenmark Pharmaceuticals Ltd. has introduced'sacubitril + valsartan' tablets in India, which are indicated for patients with chronic heart failure (NYHA class II-IV) and a low ejection fraction (HFrEF). It is marketed as 'Sacu VTM' and must be...

DCGI granted market authorisation for SII's Covid vaccine Covovax as heterologous booster dose

The Drug Controller General of India (DCGI) has approved the COVID-19 vaccine Covovax for marketing as a heterologous booster dose for adults who have received two doses of Covishield or Covaxin, according to official sources...

First G20 health summit begins January 18 in Thiruvananthapuram

The first Health Working Group (HWG) meeting under G20 India Presidency will be held between January 18-20, in Kerala's Thiruvananthapuram. As chair of the G20 Presidency, India aims to continue and consolidate health priorities and key takeaways ...

Zydus gets US FDA final approval for Febuxostat tablets for treating high uric acid

Zydus Lifesciences has said it has received final approval from the US Food and Drug Administration (US FDA) to market Febuxostat tablets for 40 mg and 80 mg...

Importance of drugs in breast cancer treatment

Since Breast cancer is one of the largest forms of cancer in the country, it has been affecting approximately over 0.21 million new female patients every year.

Apollo Hospitals launches genomics institute to provide comprehensive care to patients

Apollo Hospitals Navi Mumbai, an advanced quaternary care hospital launched the Apollo Genomics Institutes to provide comprehensive care to patients and families with genetic disorders...

IPEC India's virtual training series to focus on key global excipient regulations for generic drug development

The International Pharmaceutical Excipients Council (IPEC) India will host a virtual training series on February 9, 14, and 15, 2023, with a focus on key global excipient regulations for generic drug development...

Mark Cuban's pharmaceuticals startup ties up with RxPreferred

Mark Cuban's pharmaceuticals startup has partnered with pharmacy benefits manager RxPreferred Benefits, the companies announced, in an effort to offer lower-cost drugs through some employer-sponsored health insurance plans....

Sun Pharma launches Palbociclib to treat advanced breast cancer

Sun Pharmaceutical Industries Limited has announced that one of its wholly-owned subsidiaries has launched Palbociclib, a novel anti-cancer drug, in India for patients who have advanced breast cancer. The company will make the drug available under..

BioAsia 2023 to focus on opportunities in life science post-Covid

The event is scheduled to be held between February 24 and 26, at the Hyderabad International Convention Center (HICC) in Hyderabad. Ernst and Young will be the knowledge partner of the event...

© 2025 India Pharma Outlook. All Rights Reserved.